Search images on Google Product Monograph
Active Ingredients:
- antihemophilic factor (recombinant), pegylated, 500 UNIT/VIAL
DIN: 02459043
Dosage Form(s): KIT, POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: 100 UNITS/ML (5 ML DILUENT) - SINGLE-USE VIAL
Schedule: Schedule D
Company: TAKEDA CANADA INC – official site
ATC:
- B02 - ANTIHEMORRHAGICS (ATC, WHO, Wiki)
- B02B - VITAMIN K AND OTHER HEMOSTATICS (ATC, WHO)
- B02BD - Blood coagulation factors (ATC, WHO)
- B02BD02 - COAGULATION FACTOR VIII (WHO)
Reference brand drug:
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 5ML
External Links for Adynovate:
Search on Google
- Adynovate side effects
- Adynovate dosage
- antihemophilic factor side effects
- antihemophilic factor dosage
Takeda Canada Inc
Go to Takeda website to see drug product details. Sometimes you can find adynovate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.